Hennion & Walsh Asset Management Inc. Acquires 12,946 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Hennion & Walsh Asset Management Inc. boosted its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 34.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 50,886 shares of the company’s stock after acquiring an additional 12,946 shares during the quarter. Hennion & Walsh Asset Management Inc.’s holdings in Definitive Healthcare were worth $209,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Millennium Management LLC bought a new position in shares of Definitive Healthcare during the second quarter valued at about $9,283,000. Massachusetts Financial Services Co. MA increased its stake in Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after buying an additional 1,626,813 shares during the last quarter. 272 Capital LP bought a new position in shares of Definitive Healthcare during the 2nd quarter worth approximately $3,480,000. State Street Corp boosted its stake in shares of Definitive Healthcare by 29.4% in the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after buying an additional 317,952 shares during the last quarter. Finally, Marshall Wace LLP bought a new position in shares of Definitive Healthcare in the second quarter valued at approximately $1,535,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on DH shares. Barclays reiterated an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a report on Monday, January 13th. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Finally, Stephens began coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target for the company. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Definitive Healthcare has a consensus rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Trading Up 11.9 %

Shares of DH opened at $4.41 on Wednesday. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The business has a 50-day moving average of $4.34 and a 200 day moving average of $4.47. The firm has a market cap of $509.44 million, a P/E ratio of -1.42, a price-to-earnings-growth ratio of 2.96 and a beta of 1.41. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.03). The business had revenue of $62.70 million during the quarter, compared to analysts’ expectations of $61.66 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. During the same quarter in the previous year, the business earned $0.01 EPS. As a group, research analysts forecast that Definitive Healthcare Corp. will post 0.15 EPS for the current year.

Insider Activity

In related news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 14.84% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.